Lucintel Forecasts The Global Needle-free Injection System Market To Reach $6 Billion By 2030

By Author: Lucintel
Total Articles: 3984
Comment this article

According to the recent study the global needle-free injection system market is projected to reach an estimated $6 billion by 2030 from $2 billion in 2023 at a CAGR of 15% from 2023 to 2030. Growth in this market is primarily driven by growing prevalence of chronic diseases, the increasing incidence of communicable diseases due to needle stick injuries, and rise in demand for self-injection devices.
A more than 150-page report to understand trends, opportunities and forecast in needle-free injection system market by product (fillable needle-free injectors and prefilled needle-free injectors), technology (jet-based needle-free injectors, etc.), usability (reusable and disposable needle-free injectors), type of medication (liquid-based needle-free injectors, powder-based needle-free injectors, etc.), site of delivery (intradermal injectors, intramuscular injectors, etc.), application (vaccine needle-free delivery, insulin needle-free delivery, etc.), end users (hospitals and clinics, homecare settings, etc.), and regions.
Based on technology, the needle-free injection system market is segmented into jet-based needle-free ...
... injectors, spring-based needle-free injectors, laser-powered needle-free injectors, and vibration-based needle-free injectors. Lucintel forecasts that the jet-based needle-free injector market is expected to remain the largest segment accounted for the largest share as it helps in preventing needlestick injuries to healthcare providers and overcomes the drawbacks of improper and unsterile reuse of needles & syringes.
Download sample by clicking on needle-free injection system market.
Based on product the prefilled needle-free injectors segment is expected to witness the highest growth over the forecast period due to the majority of these prefilled syringes are automated and thus reducing the risk of physical handling and ensuring a safer use.
North America is expected to remain the largest market during the forecast period mainly due growing prevalence of chronic disease and rising demand for self-injection systems contribute to North America driving the market. APAC is likely to witness the highest growth over the forecast period due to the expansion of private-sector hospitals and clinics to rural areas, the availability of low-cost labor for manufacturing.
Major players of needle-free injection system market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Endo International plc, Ferring Pharmaceuticals, Penjet Corporation, Medical International Technology Inc., PharmaJet are among the major needle-free injection system providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Sugarcane Wax Market
Deoxidizer Market
Hydrogen Cyanide Market
Propyl Gallate Market
Silica Sol Market
Sulfonic Acid Market